Background Extensive drug resistance of Acinetobacter baumannii is a serious problem in
the clinical setting. It is therefore important to find active antibiotic combinations that could be …

Infections by multidrug-resistant Acinetobacter baumannii constitute an increasing threat for
critically ill patients. Colistin is often the only antimicrobial retaining activity against these …

Objectives The increased incidence of nosocomial infections by multidrug-resistant
organisms has motivated the re-introduction of colistin in combination with other …

Objectives The study investigated the effect of colistin and minocycline when tested singly
and in combination against Acinetobacter baumannii. Methods Thirteen unrelated imipenem …

Background Acinetobacter baumannii has emerged as a major cause of nosocomial
outbreaks. It is particularly associated with nosocomial pneumonia and bloodstream …

Background Nosocomial infections due to multi-drug resistant Acinetobacter baumannii are
often treated with colistin, but there are few data comparing its safety and efficacy with other …

Background. Extensively drug-resistant (XDR) Acinetobacter baumannii may cause serious
infections in critically ill patients. Colistin often remains the only therapeutic option. Addition …

Objectives: We aimed to assess the efficacy and safety of a high loading dose of colistin and
no loading dose of colistin to treat multidrug-resistant (MDR) Acinetobacter baumannii …

INTRODUCTION: The increased incidence of nosocomial infections by multi-drug resistant
Acinetobacter baumannii creates demand on the application of some combinations of older …

Multidrug-resistant Acinetobacter baumannii infection has presented a global medical
challenge. The antibiograms of paired colistin-susceptible and-resistant strains revealed …